Apidra SoloStar

Apidra SoloStar

insulin glulisine

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Concise Prescribing Info
Contents
Insulin glulisine
Indications/Uses
Adults, adolescents & childn ≥6 yr w/ DM.
Dosage/Direction for Use
Individualized dosing by SC inj or continuous SC pump infusion.
Administration
Should be taken with food: Administer w/in 15 min before or soon after meals.
Contraindications
Special Precautions
Transfer to another type or brand of insulin. Hyper- & hypoglycemia. Activity or diet changes; illness or emotional disturbances. Allergic reactions due to metacresol. Combination w/ pioglitazone. May affect ability to drive & use machines. Hepatic impairment. Pregnancy & lactation. Childn <6 yr.
Adverse Reactions
Hypoglycaemia. Inj site & local hypersensitivity reactions.
Drug Interactions
Enhanced blood glucose-lowering activity & increased susceptibility to hypoglycaemia by oral antidiabetics, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates, sulfonamide antibiotics. Reduced blood glucose-lowering activity by corticosteroids, danazol, diazoxide, diuretics, glucagon, INH, phenothiazine derivatives, somatropin, sympathomimetics, thyroid hormones, estrogens, progestins, PIs, atypical antipsychotics. Potentiated or weakened insulin effects by β-blockers, clonidine, lithium salts or alcohol. Hypoglycaemia followed by hyperglycaemia w/ pentamidine. Reduced or absent signs of adrenergic counterregulation w/ sympatholytics eg, β-blockers, clonidine, guanethidine, reserpine.
ATC Classification
A10AB06 - insulin glulisine ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Apidra SoloStar pre-filled pen 300 U/3 mL
Packing/Price
(Solostar) 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in